| ESPEN guidelines on enteral nutrition: liver disease M Plauth, E Cabre, O Riggio, M Assis-Camilo, M Pirlich, J Kondrup, ... Clinical nutrition 25 (2), 285-294, 2006 | 1031 | 2006 |
| Incidence and natural history of small esophageal varices in cirrhotic patients M Merli, G Nicolini, S Angeloni, V Rinaldi, A De Santis, C Merkel, AF Attili, ... Journal of hepatology 38 (3), 266-272, 2003 | 783 | 2003 |
| Does malnutrition affect survival in cirrhosis? M Merli, O Riggio, L Dally Hepatology 23 (5), 1041-1046, 1996 | 459 | 1996 |
| Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial P Caraceni, O Riggio, P Angeli, C Alessandria, S Neri, FG Foschi, ... The Lancet 391 (10138), 2417-2429, 2018 | 449 | 2018 |
| Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites F Salerno, M Merli, O Riggio, M Cazzaniga, V Valeriano, M Pozzi, ... Hepatology 40 (3), 629-635, 2004 | 413 | 2004 |
| Cirrhotic patients are at risk for health care–associated bacterial infections M Merli, C Lucidi, V Giannelli, M Giusto, O Riggio, M Falcone, L Ridola, ... Clinical Gastroenterology and Hepatology 8 (11), 979-985. e1, 2010 | 374 | 2010 |
| MELD score is better than Child–Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt F Salerno, M Merli, M Cazzaniga, V Valeriano, P Rossi, A Lovaria, ... Journal of hepatology 36 (4), 494-500, 2002 | 368 | 2002 |
| Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts O Riggio, S Angeloni, FM Salvatori, A De Santis, F Cerini, A Farcomeni, ... Official journal of the American College of Gastroenterology| ACG 103 (11 …, 2008 | 348 | 2008 |
| The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology J Trebicka, J Fernandez, M Papp, P Caraceni, W Laleman, C Gambino, ... Journal of hepatology 73 (4), 842-854, 2020 | 336 | 2020 |
| Nutritional status: its influence on the outcome of patients undergoing liver transplantation M Merli, M Giusto, F Gentili, G Novelli, G Ferretti, O Riggio, SG Corradini, ... Liver international 30 (2), 208-214, 2010 | 333 | 2010 |
| Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt O Riggio, S Nardelli, F Moscucci, C Pasquale, L Ridola, M Merli Clinics in liver disease 16 (1), 133-146, 2012 | 303* | 2012 |
| Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study M Merli, M Giusto, C Lucidi, V Giannelli, I Pentassuglio, V Di Gregorio, ... Metabolic brain disease 28, 281-284, 2013 | 273 | 2013 |
| Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study O Riggio, A Masini, C Efrati, F Nicolao, S Angeloni, FM Salvatori, M Bezzi, ... Journal of hepatology 42 (5), 674-679, 2005 | 254 | 2005 |
| Antithrombotic treatment with direct‐acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis A De Gottardi, J Trebicka, C Klinger, A Plessier, S Seijo, B Terziroli, ... Liver International 37 (5), 694-699, 2017 | 239 | 2017 |
| High prevalence of spontaneous portal‐systemic shunts in persistent hepatic encephalopathy: a case‐control study O Riggio, C Efrati, C Catalano, F Pediconi, O Mecarelli, N Accornero, ... Hepatology 42 (5), 1158-1165, 2005 | 228 | 2005 |
| Modification of cardiac function in cirrhotic patients with and without ascites V Valeriano, S Funaro, R Lionetti, O Riggio, G Pulcinelli, P Fiore, A Masini, ... Official journal of the American College of Gastroenterology| ACG 95 (11 …, 2000 | 214 | 2000 |
| Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial M Merli, F Salerno, O Riggio, R de Franchis, F Fiaccadori, P Meddi, ... Hepatology 27 (1), 48-53, 1998 | 210 | 1998 |
| Sarcopenia is risk factor for development of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt placement S Nardelli, B Lattanzi, S Torrisi, F Greco, A Farcomeni, S Gioia, M Merli, ... Clinical Gastroenterology and Hepatology 15 (6), 934-936, 2017 | 209 | 2017 |
| Polytetrafluoroethylene-covered nitinol stent-graft for transjugular intrahepatic portosystemic shunt creation: 3-year experience P Rossi, FM Salvatori, F Fanelli, M Bezzi, M Rossi, G Marcelli, D Pepino, ... Radiology 231 (3), 820-830, 2004 | 206 | 2004 |
| Efficacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice S Angeloni, C Leboffe, A Parente, M Venditti, A Giordano, M Merli, ... World journal of gastroenterology: WJG 14 (17), 2757, 2008 | 200 | 2008 |
